Cardiovascular disease ("CVD") is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD. CVD accounts for one in every three deaths in the US, or more than ...
Allelica, a precision medicine company focused on genomic risk assessment for common diseases, today announced that it has entered into a commercial license agreement with Cambridge Enterprise, the ...
A polygenic risk score (PRS) may help identify women who are at a greater risk of developing a future breast cancer after treatment for in situ breast disease, a retrospective study suggests. The ...
Bottom Line: In a retrospective study, the 313-SNP breast cancer polygenic risk score (PRS 313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in ...
Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...
USA: Researchers have discovered in a new research that bronchodilator responsiveness (BDR) shows a stronger association with ...
Human embryo screening undermines parental trust, stigmatizes disability, narrows genetic diversity, and erodes the foundation of unconditional love. Artificial intelligence compounds these dangers by ...
Stockhead on MSN
Rhythm Biosciences enhances GeneType colorectal cancer test with clinical and lifestyle risk factors
Rhythm Biosciences has upgraded its geneType colorectal cancer test with additional lifestyle and clinical risk factors. ...
The addition of polygenic risk scores (PRS) improved the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT across all groups studied, across ancestries. Over 3 million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback